HIV Protease Substrate 1 (TFA)

• UNSPSC Description:

  HIV Protease Substrate 1 TFA, a fiuorogenic HIV protease substrate, can be used to study enzymatic activity of HIV protease[1].

• Target Antigen:

  HIV Protease

• Type:

  Peptides

• Related Pathways:

  Anti-infection;Metabolic Enzyme/Protease

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/hiv-protease-substrate-1-tfa.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCC(NCCNC1=CC=CC2=C1C=CC=C2S(=O)(O)=O)=O)NC([C@H](CCCNC(N)=N)N)=O)=O)CO)=O)CCC(N)=O)=O)CC(N)=O)=O)CC3=CC=C(O)C=C3)N4[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)CCCCNC(C5=CC=C(/N=N/C6=CC=C(N(C)C)C=C6)C=C5)=O)=O)CCC(N)=O)=O)C(C)C)=O)[C@H](CC)C)=O)CCC4.O=C(O)C(F)(F)F

• Molecular Weight:

  2131.29

• References & Citations:

  [1]Kapewangolo P, et al. Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a. Molecules. 2017;22(11):1763. Published 2017 Nov 6.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported